Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PACB | TMO | ISRG | EW | DXCM |
| Company | Pacific Biosciences | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Edwards Lifesciences Corp | Dexcom Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 1.3900 | 534.80 | 372.57 | 87.35 | 134.36 |
| High | 1.5000 | 544.87 | 375.33 | 87.35 | 135.99 |
| Low | 1.2900 | 529.64 | 369.15 | 85.98 | 133.58 |
| Last | 1.4600 | 541.52 | 372.63 | 86.45 | 134.30 |
| Change | +0.0600 | -5.73 | -1.54 | -0.79 | +0.44 |
| % Change | +4.29% | -1.05% | -0.41% | -0.91% | +0.33% |
| Volume | 18,711,773 | 2,075,756 | 2,272,280 | 3,121,953 | 2,115,900 |
| 20-Day Average Volume | 11,543,434 | 1,261,333 | 1,442,984 | 3,013,053 | 2,446,670 |
| Previous Close | 1.4000 | 547.25 | 374.17 | 87.24 | 133.86 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.1628 | 571.40 | 387.43 | 92.14 | 137.29 |
| 20-Day Raw Stochastic | 7.37% | 19.70% | 10.06% | 4.64% | 27.63% |
| 20-Day Relative Strength | 22.31% | 37.18% | 42.92% | 42.25% | 51.87% |
| Weighted Alpha | -83.01 | -2.29 | +25.62 | +5.21 | +17.30 |
| Today's Opinion | 100% Sell | 40% Buy | 56% Buy | 56% Buy | 88% Buy |
| Previous Opinion | 100% Sell | 40% Buy | 56% Buy | 56% Buy | 88% Buy |
| Last Month's Opinion | 100% Sell | 100% Buy | 100% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -56.80% since 04/11/24 | -5.75% since 04/11/24 | -5.00% since 04/11/24 | -5.43% since 04/11/24 | -3.81% since 04/11/24 |
| Low | 1.2500 on 04/17/24 | 529.64 on 04/18/24 | 369.15 on 04/18/24 | 85.98 on 04/18/24 | 132.88 on 04/17/24 |
| High | 3.3500 on 04/12/24 | 573.39 on 04/12/24 | 392.29 on 04/15/24 | 91.73 on 04/15/24 | 138.77 on 04/12/24 |
| 1-Month | |||||
| %Chg | -60.22% since 03/18/24 | -6.64% since 03/18/24 | -5.09% since 03/18/24 | -6.89% since 03/18/24 | -0.31% since 03/18/24 |
| Low | 1.2500 on 04/17/24 | 529.64 on 04/18/24 | 369.15 on 04/18/24 | 85.98 on 04/18/24 | 131.31 on 03/20/24 |
| High | 4.1000 on 03/21/24 | 589.93 on 04/09/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 142.00 on 03/26/24 |
| 3-Month | |||||
| %Chg | -77.04% since 01/18/24 | -0.53% since 01/18/24 | +0.19% since 01/18/24 | +16.13% since 01/18/24 | +5.37% since 01/18/24 |
| Low | 1.2500 on 04/17/24 | 529.64 on 04/18/24 | 362.14 on 01/24/24 | 71.92 on 01/25/24 | 113.05 on 02/28/24 |
| High | 7.5000 on 01/26/24 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 142.00 on 03/26/24 |
| 6-Month | |||||
| %Chg | -80.92% since 10/18/23 | +15.89% since 10/18/23 | +35.25% since 10/18/23 | +24.01% since 10/18/23 | +59.65% since 10/18/23 |
| Low | 1.2500 on 04/17/24 | 415.60 on 10/25/23 | 254.85 on 10/30/23 | 60.57 on 10/30/23 | 80.93 on 10/26/23 |
| High | 10.6500 on 12/27/23 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 142.00 on 03/26/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 375,133 | 208,892,976 | 132,624,192 | 52,512,112 | 51,605,040 |
| Shares Outstanding, K | 267,952 | 381,714 | 354,449 | 601,927 | 385,515 |
| Annual Sales | 200,520,000 | 42,857,000,000 | 7,124,100,000 | 6,004,800,000 | 3,622,300,000 |
| Annual Net Income | -306,740,000 | 5,995,000,000 | 1,798,000,000 | 1,402,400,000 | 541,500,000 |
| Last Quarter Sales | 58,360,000 | 10,886,000,000 | 1,928,300,000 | 1,534,100,000 | 1,034,500,000 |
| Last Quarter Net Income | -82,020,000 | 1,630,000,000 | 606,200,000 | 369,900,000 | 256,300,000 |
| 60-Month Beta | 1.83 | 0.80 | 1.36 | 1.05 | 1.20 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.27 on 02/15/24 | 5.67 on 01/31/24 | 1.60 on 01/23/24 | 0.64 on 02/06/24 | 0.50 on 02/08/24 |
| Latest Earnings Date | 05/07/24 | 04/24/24 | 04/18/24 | 04/25/24 | 04/25/24 |
| Most Recent Dividend | N/A | 0.390 on 03/14/24 | N/A | N/A | N/A |
| Next Ex-Dividends Date | N/A | 03/14/24 | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.75 | 83.75 | 35.88 | 90.41 |